96 related articles for article (PubMed ID: 30741086)
1. Prescriber Variation in Relation to Prescribing Trends within the Preferred Drugs Initiative in Ireland (2012-2015): An Interrupted Time-Series Study Using Latent Curve Models.
McDowell RD; Bennett K; Moriarty F; Clarke S; Barry M; Fahey T
Med Decis Making; 2019 Apr; 39(3):278-293. PubMed ID: 30741086
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011
McDowell R; Bennett K; Moriarty F; Clarke S; Barry M; Fahey T
BMJ Open; 2018 Apr; 8(4):e019315. PubMed ID: 29678966
[TBL] [Abstract][Full Text] [Related]
3. Prescriber variation in potentially inappropriate prescribing in older populations in Ireland.
Cahir C; Fahey T; Teljeur C; Bennett K
BMC Fam Pract; 2014 Apr; 15():59. PubMed ID: 24690127
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
Moriarty F; Bennett K; Cahir C; Fahey T
J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
[TBL] [Abstract][Full Text] [Related]
5. Effect of prescriber education on the use of medications contraindicated in older adults in a managed medicare population.
Kaufman MB; Brodin KA; Sarafian A
J Manag Care Pharm; 2005 Apr; 11(3):211-9. PubMed ID: 15804205
[TBL] [Abstract][Full Text] [Related]
6. Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study.
Boland F; Galvin R; Reulbach U; Motterlini N; Kelly D; Bennett K; Fahey T
BMC Pediatr; 2015 Sep; 15():118. PubMed ID: 26357902
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland.
O'Sullivan K; Reulbach U; Boland F; Motterlini N; Kelly D; Bennett K; Fahey T
BMJ Open; 2015 Jun; 5(6):e007070. PubMed ID: 26059522
[TBL] [Abstract][Full Text] [Related]
8. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
Abrams TE; Lund BC; Bernardy NC; Friedman MJ
Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
[TBL] [Abstract][Full Text] [Related]
9. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis.
Chang HY; Lyapustina T; Rutkow L; Daubresse M; Richey M; Faul M; Stuart EA; Alexander GC
Drug Alcohol Depend; 2016 Aug; 165():1-8. PubMed ID: 27264166
[TBL] [Abstract][Full Text] [Related]
10. Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines.
Zwar N; Wolk J; Gordon J; Sanson-Fisher R; Kehoe L
Fam Pract; 1999 Oct; 16(5):495-500. PubMed ID: 10533946
[TBL] [Abstract][Full Text] [Related]
11. Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia.
Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H
BMJ Qual Saf; 2020 May; 29(5):365-373. PubMed ID: 31641029
[TBL] [Abstract][Full Text] [Related]
12. Beginners in prescribing practice: Experiences and perceptions of nurses and doctors.
Lim AG; North N; Shaw J
J Clin Nurs; 2018 Mar; 27(5-6):1103-1112. PubMed ID: 29076584
[TBL] [Abstract][Full Text] [Related]
13. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
14. Development of an Institutional Opioid Prescriber Education Program and Opioid-Prescribing Guidelines: Impact on Prescribing Practices.
Stepan JG; Lovecchio FC; Premkumar A; Kahlenberg CA; Albert TJ; Baurley JW; Nwachukwu BU
J Bone Joint Surg Am; 2019 Jan; 101(1):5-13. PubMed ID: 30601411
[TBL] [Abstract][Full Text] [Related]
15. High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines.
Eriksen J; Gustafsson LL; Ateva K; Bastholm-Rahmner P; Ovesjö ML; Jirlow M; Juhasz-Haverinen M; Lärfars G; Malmström RE; Wettermark B; Andersén-Karlsson E;
BMJ Open; 2017 May; 7(4):e014345. PubMed ID: 28465306
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors: potential cost reductions by applying prescribing guidelines.
Cahir C; Fahey T; Tilson L; Teljeur C; Bennett K
BMC Health Serv Res; 2012 Nov; 12():408. PubMed ID: 23163956
[TBL] [Abstract][Full Text] [Related]
17. Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study.
Cadogan CA; Bradley CP; Bennett K
Eur J Clin Pharmacol; 2021 Jun; 77(6):903-912. PubMed ID: 33410969
[TBL] [Abstract][Full Text] [Related]
18. Validation of prescriber risk indicators obtained from prescription drug monitoring program data.
Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317
[TBL] [Abstract][Full Text] [Related]
19. Prescribing differences among older adults with differing health cover and socioeconomic status: a cohort study.
Prendergast C; Flood M; Murry LT; Clyne B; Fahey T; Moriarty F
BMC Geriatr; 2023 Nov; 23(1):755. PubMed ID: 37978448
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study.
O Riordan D; Aubert CE; Walsh KA; Van Dorland A; Rodondi N; Du Puy RS; Poortvliet RKE; Gussekloo J; Sinnott C; Byrne S; Galvin R; Jukema JW; Mooijaart SP; Baumgartner C; McCarthy V; Walsh EK; Collet TH; Dekkers OM; Blum MR; Kearney PM
BMJ Open; 2018 Mar; 8(3):e019003. PubMed ID: 29567842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
